Printer Friendly

DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES ADDITION OF TWO KEY MARKETING EXECUTIVES

 DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES ADDITION
 OF TWO KEY MARKETING EXECUTIVES
 COLUMBUS, Ohio, June 22 /PRNewswire/ -- Danninger Medical Technology, Inc. (NASDAQ: DANN) today announced the addition of new marketing executives for the Recovery Products Division and Cross Medical Products, Inc., a wholly owned subsidiary. Both of these management positions were established to significantly expand the domestic and global markets for each company's products and devices. Specific emphasis will be directed toward increased market share of current products as well as the establishment of strong distribution capabilities for new products.
 Douglas J. Marken has been named vice president-marketing of the Recovery Products Division. He will be responsible for further expansion of the Specialty Dealer Program, introduced in the fourth quarter of 1991; increased penetration of other existing products; and expanding products offerings within the Recovery Division.
 Most recently, Marken served as senior product manager for SCIMED Life Systems with responsibility for all marketing and business functions of a $30 million business segment. From June, 1981 to September, 1991, he served as Market Development Manager and Senior Account Representative for 3M Orthopedic Products Division. Marken earned a bachelor of arts degree in bio-physics from Wittenberg University (1977) and has completed course work toward an MBA degree from College of St. Thomas in St. Paul, Minn.)
 Ira Benson has been named vice-president-marketing for Cross Medical Products, Inc. His primary responsibilities will include development and implementation of a comprehensive marketing plan for Cross; marketing support for the Puno/Winter/Byrd Pedicle Screw/ Rod System, currently subject to an FDA Investigational Device Exemption; and expansion of distribution of the PWB Lumbosacral System, which recently received FDA marketing clearance. He has management experience in successful implementation of strategic marketing plans with Bristol-Myers, Eli Lilly, and G.D. Searle, in orthopedic, cardiovascular and urological products.
 Benson held management positions with Orthomet Corporation (Minneapolis) since November, 1988. Most recently, he served as vice president-marketing, a member of the executive staff, and was responsible for domestic and international marketing. Prior to that experience, Benson was group product marketing manager for Eli Lilly and Company-Cardiac Pacemaker, Inc. (St. Paul, Minn.). Benson received a bachelor of science-business administration degree from The Pennsylvania State University (1977).
 Joseph A. Mussey, president, commented, "We are pleased to announce these key management additions. Both of these individuals have considerable experience in development and implementation of successful market plans for health care companies. During the past two years the company has been pursuing a plan to further strengthen the management team and position Danninger for significant growth and profitability, and we look forward to the future with increased optimism."
 Danninger Medical Technology, Inc. designs, manufactures, and markets medical devices that assist patients in their recovery following surgery or trauma. Danninger is a leader in anufactures and markets spinal implants subject of specific FDA approvals and orthopedic surgical instrumentation.
 -0- 6/22/92
 /CONTACT: Joseph A. Mussey, president of Danninger Medical Technology, Inc., 614-276-8267/
 (DANN) CO: Danninger Medical Technology, Inc. ST: Ohio IN: MTC SU: PER


LC -- CL009 -- 2387 06/22/92 12:03 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 22, 1992
Words:508
Previous Article:USDA AUDIT ADMITS AGENCY NOT PROTECTING PUPPY MILL PUPPIES, HSUS SAYS
Next Article:DBA SYSTEMS ANNOUNCES OFFERING
Topics:


Related Articles
ALCO INTERNATIONAL ANNOUNCES ELECTION OF B. ROLAND FREASIER JR. AS CHAIRMAN OF THE BOARD
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES HIGHER SECOND QUARTER AND FIRST HALF RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. REPORTS RECORD FIRST QUARTER SALES
DANNINGER MEDICAL TECHNOLOGY, INC. SUBSIDIARY RECEIVES FDA MARKET CLEARANCE FOR THE SYNERGY SPINAL TITANIUM ANTERIOR SPINAL SYSTEM
DANNINGER MEDICAL TECHNOLOGY, INC. REPORTS HIGHER SALES, NET LOSS DUE TO SYNERGY SPINAL IMPLANT SYSTEM INTRODUCTION
HEMASURE ANNOUNCES ADDITIONS TO AND REAPPOINTMENTS WITHIN SENIOR MANAGEMENT TEAM
DANNINGER MEDICAL TECHNOLOGY, INC. COMPLETES DEBENTURE OFFERING
DANNINGER MEDICAL TECHNOLOGY, INC. ELECTS TWO DIRECTORS; CLOSES CONVERTIBLE DEBENTURE OFFERING
Danninger Acquires Rehabilitation Device Rental Company
A. Oelschlaeger Joins Meridian as General Manager, Cardiopulmonary Systems

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters